Angiotensin II receptor blocker, valsartan, increases myocardial blood volume and regresses hypertrophy in hypertensive patients

Circulation Journal

Volumn 73, Issue 11, 2009, Pages 2098-2103

  Komatsu, Hiroshi ^a   Yamada, Satoshi ^a   Iwano, Hiroyuki ^a   Okada, Masako ^a   Onozuka, Hisao ^b   Mikami, Taisei ^b   Yokoyama, Shinobu ^c   Inoue, Mamiko ^c   Kaga, Sanae ^c   Nishida, Mutsumi ^c   Shimizu, Chikara ^c   Matsuno, Kazuhiko ^c   Tsutsui, Hiroyuki ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Angiotensin; Blood volume; Echocardiography; Hypertension; Left ventricular hypertrophy

Indexed keywords

ANGIOTENSIN RECEPTOR; VALSARTAN;

ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE; BLOOD VOLUME; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE; HUMAN; HYPERTENSION; HYPERTROPHY; MALE;

ADULT; AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BLOOD PRESSURE; BLOOD VOLUME; CASE-CONTROL STUDIES; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; TETRAZOLES; VALINE;

EID: 73249132720     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-09-0324     Document Type: Article

References (26)

1. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561-1566.
2. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114: 345-352.
3. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Gattobigio R, Zampi I, et al. Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation 1998; 97: 48-54.
4. Mathew J, Sleight P, Lonn E, Johnstone D, Pogue J, Yi Q, et al. Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril. Circulation 2001; 104: 1615-1621.
5. Frohlich ED. Fibrosis and ischemia: The real risks in hypertensive heart disease. Am J Hypertens 2001; 14: 194S-199S.
6. Feihl F, Liaudet L, Levy BI, Waeber B. Hypertension and microvascular remodelling. Cardiovasc Res 2008; 78: 274-285.
7. Rakusan K, Flanagan MF, Geva T, Southern J, Van Praagh R. Morphometry of human coronary capillaries during normal growth and the effect of age in left ventricular pressure-overload hypertrophy. Circulation 1992; 86: 38-46.
8. Heagerty AM, Aalkjaer C, Bund SJ, Korsgaard N, Mulvany MJ. Small artery structure in hypertension: Dual processes of remodeling and growth. Hypertension 1993; 21: 391-397.
9. Mulvany MJ, Baumbach GL, Aalkjaer C, Heagerty AM, Korsgaard N, Schiffrin EL, et al. Vascular remodeling. Hypertension 1996; 28: 505-506.
10. Mundhenke M, Schwartzkopff B, Strauer BE. Structural analysis of arteriolar and myocardial remodelling in the subendocardial region of patients with hypertensive heart disease and hypertrophic cardiomyopathy. Virchows Arch 1997; 431: 265-273.
11. Shaw LM, George PR, Oldham AA, Heagerty AM. A comparison of the effect of angiotensin converting enzyme inhibition and angiotensin II receptor antagonism on the structural changes associated with hypertension in rat small arteries. J Hypertens 1995; 13: 1135-1143.
12. Rizzoni D, Porteri E, Piccoli A, Castellano M, Bettoni G, Muiesan ML, et al. Effects of losartan and enalapril on small artery structure in hypertensive rats. Hypertension 1998; 32: 305-310.
13. Schiffrin EL, Deng LY, Larochelle P. Effects of a beta-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension. Hypertension 1994; 23: 83-91.
14. Schiffrin EL, Park JB, Intengan HD, Touyz RM. Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan. Circulation 2000; 101: 1653-1659.
15. Schwartzkopff B, Brehm M, Mundhenke M, Strauer BE. Repair of coronary arterioles after treatment with perindopril in hypertensive heart disease. Hypertension 2000; 36: 220-225.
16. Vogel R, Indermuhle A, Reinhardt J, Meier P, Siegrist PT, Namdar M, et al. The quantification of absolute myocardial perfusion in humans by contrast echocardiography: Algorithm and validation. J Am Coll Cardiol 2005; 45: 754-762.
17. Yamada S, Komuro K, Mikami T, Kudo N, Onozuka H, Goto K, et al. Novel quantitative assessment of myocardial perfusion by harmonic power Doppler imaging during myocardial contrast echocardiography. Heart 2005; 91: 183-188.
18. Indermuhle A, Vogel R, Meier P, Wirth S, Stoop R, Mohaupt MG, et al. The relative myocardial blood volume differentiates between hypertensive heart disease and athlete's heart in humans. Eur Heart J 2006; 27: 1571-1578.
19. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440-1463.
20. Kassab GS, Fung YC. Topology and dimensions of pig coronary capillary network. Am J Physiol 1994; 267: H319-H325.
21. Korsgaard N, Aalkjaer C, Heagerty AM, Izzard AS, Mulvany MJ. Histology of subcutaneous small arteries from patients with essential hypertension. Hypertension 1993; 22: 523-526.
22. Schiffrin EL, Touyz RM. From bedside to bench to bedside: Role of renin-angiotensin-aldosterone system in remodeling of resistance arteries in hypertension. Am J Physiol Heart Circ Physiol 2004; 287: H435-H446.
23. Komukai K, Yagi H, Ogawa T, Date T, Morimoto S, Kawai M, et al. Inhibition of the renin-angiotensin system prevents re-hospitalization of heart failure patients with preserved ejection fraction. Circ J 2008; 72: 2004-2008.
24. Kawasaki D, Kosugi K, Waki H, Yamamoto K, Tsujino T, Masuyama T. Role of activated renin-angiotensin system in myocardial fibrosis and left ventricular diastolic dysfunction in diabetic patients: Reversal by chronic angiotensin II type 1A receptor blockade. Circ J 2007; 71: 524-529.
25. Pries AR, Habazettl H, Ambrosio G, Hansen PR, Kaski JC, Schachinger V, et al. A review of methods for assessment of coronary microvascular disease in both clinical and experimental settings. Cardiovasc Res 2008; 80: 165-174.
26. Mohlenkamp S, Lerman LO, Lerman A, Behrenbeck TR, Katusic ZS, Sheedy PF 2nd, et al. Minimally invasive evaluation of coronary microvascular function by electron beam computed tomography. Circulation 2000; 102: 2411-2416.